|
|
 |
|
Viewing report
|
|
|
|
Combination Therapy for Asthma and Chronic Obstructive Pulmonary Disease
Informa Healthcare, April 2000, Pages: 336
This book examines the therapies used for treatment of asthma and chronic obstructive pulmonary disease (COPD) separately and in combination, covering beta-agonists, theophylline, leukotriene modifiers, and anticholinergics.
Highlights the importance of specific time dosing of medications!
Revealing what medications to use and when to prescribe them, Combination Therapy for Asthma and Chronic Obstructive Pulmonary Disease
- emphasizes anti-inflammatory therapy
- compares and contrasts the side effects and efficacy of titration and various combinations
- covers the steroid-sparing effect of combining inhaled corticosteroids and long-acting beta 2-agonists
- includes over 1100 references that clarify outcomes among several different agents
- details the mechanisms of inhaled glucocorticoid action
- and more!
Written by clinicians who are experts in the pharmacological agents discussed, Combination Therapy for Asthma and Chronic Obstructive Pulmonary Disease is critical for pulmonologists, clinical immunologists/allergists, pharmacologists, internists, family practice physicians, pediatricians, and hospital interns and residents.
Customers who bought this item also bought
Chronic Obstructive Pulmonary Disease (COPD): KOL Insights on Treatment Practices and Unmet Needs
Asthma: KOL Insights on Treatment Practices and Unmet Needs
Advances in Combination Therapy for Asthma and COPD
European Asthma Therapeutics Markets
Biomarker and Diagnostic Opportunities in Respiratory Diseases
Nitric Oxide - Therapeutics, Markets and Companies
Vitamin D. Edition No. 3
Delivering Drugs by Inhalation
SPECIAL REPORT: How Will the Withdrawal of Generic Albuterol Change the U.S. Respiratory Disease Market?
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010
|
|
|
|
